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G-protein coupled receptors (GPCR) play an essential role in human physiology. They are 
prominent pharmacological targets and the understanding of molecular mechanisms underlying 
their activity is fundamental for the design of new drugs. Since a decade, a number of 3D 
structures have been elucidated, but sparse in complex with peptide agonists. We will present 
two examples of the characterization by liquid state NMR of the structure and dynamics of 
neuropeptides bound to their receptor, dynorphin and ghrelin. 
 
Dynorphin: 
The opioid receptor family contains four subtypes MOP, DOP, KOP and NOP, each activated 
by specific neuropeptides. The kappa-opioid receptor (KOP) mediates the actions of opioids 
with hallucinogenic, dysphoric, and analgesic activities. Its endogenous agonist is dynorphin 
A, a 17 amino acid long peptide, of sequence YGGFLRRIRPKLKWDNQ. The KOP 3D 
structure was first solved in 2012, KOP being in complex with an antagonist, JDTic (1). More 
recently, a new KOP structure was solved, in the presence of a nanobody mimicking G-proteins 
and an agonist (2). These two structures reveal the major structural changes associated with 
KOP activation by an agonist and provide a wealth of detailed information on the molecular 
interactions driving these conformational changes. However, they do not fully explain the 
activation mechanism by dynorphin itself.  
Using NMR, we characterized the structure and dynamics of dynorphin 1-13 (a shorter, fully 
active analogue of Dynorphin A) bound to KOP, and in the absence of G-protein (3). Using 
transferred NOE experiments we observed the formation of a helical conformation extending 
from residue L5 to R9 (Fig. 1A). 15N relaxation rate measurements provided a profile of N-H 
vector order parameters along the peptide sequence (Fig 1B). This is a direct measure of the 
conformational flexibility of dynorphin bound to KOP. It confirmed the flexibility of the last 
four residues, which was expected in the context of the “message-address” concept (4). We also 
found that the first 4 residues retained a high degree of internal motion when bound to KOP. 
This was much less expected since it was known that the receptor - peptide recognition is 
extremely dependent on the exact sequence in the “message” part of opioid peptides, YGGFL. 
It provided the first accurate quantification of internal dynamics of a neuropeptide in its 
receptor-bound state. Receptor and peptide dynamics are known to be essential parameters of 
GPCRs activation (5) and one should consider this residual dynamics as an essential feature of 
the receptor activation mechanism. 
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Figure 1: A) receptor-bound conformation of dynorphin 1-13: a helical conformation is formed 
between F4 and R9;  B) Order parameter profile of dynorphin N-H bonds in the receptor-bound 
state. Grey: experimental data; White: calculated S2 profiles from molecular dynamics 
simulations of dynorphin – receptor complexes. Note that both the N- and C-termini remain 
flexible in the receptor-bound state. 
 
Dynorphin is known to bind to KOP in its G-protein decoupled state with a 10 fold reduced 
affinity compared to its G-protein coupled, fully activated state. It is thus expected that both the 
structure and dynamics of dynorphin should be different in the activated state. Based on the 
recent publication of the 3D structure of KOP bound to an agonist and a nanobody (2), we could 
extend our NMR observations to the ternary complex dynorphin – KOP – nanobody, and we 
will present the results during the Biomembranes’18 conference. 
 
Ghrelin: 
Ghrelin is a lipopeptide hormone involved in phenomena such as appetite, growth hormone 
secretion and reward-seeking behaviors. It is the natural ligand of the growth hormone 
secretagogue receptor (GHSR). A strategy similar to the one presented above was applied to 
the Ghrelin - GHSR pair. The perdeuterated receptor reconstituted into lipid nanodiscs after 
expression in E. coli (6) allowed studying Ghrelin in its bound state by liquid state NMR. We 
performed transferred 1H NOE experiments to determine the hormone’s conformation and we 
measured 15N transverse relaxation to decipher the conformational flexibility along its 
sequence. Consistent with pharmacological data, Ghrelin amino-terminal part folds with its acyl 
chain to form a hydrophobic core essential for GHSR binding and activation. In contrast, the 
carboxy-terminal part remains flexible and may participate in the binding with the receptor 
through electrostatic interactions. Furthermore, we combined NMR data with molecular 
dynamics simulations to build an ensemble of Ghrelin-GHSR complexes and thus reproduce 
the order parameter profile determined experimentally. 
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Figure 2: A) peptide sequence of the Ghrelin analogue used in the present study. The differences 
with the natural sequence are highlighted in red. B) Ghrelin receptor-bound conformation 
determined from trNOE data. C) It is characterized by a well-defined hydrophobic core formed 
by the acyl chain (which is essential for ghrelin’s activity) and the Phe4 and Leu5 side chains. 
 
This approach provides the first active structure of Ghrelin and a novel insight into the 
molecular mechanisms responsible for its activity with respect to the activation of GHSR. Here 
again, the results were obtained in the absence of G-proteins, and extension of this work will 
involve using a ternary complex peptide – receptor – G protein (or a mimic of G proteins).  
Considering the pharmacological relevance of Ghrelin and its receptor, our results may lead to 
the design of new drugs with applications in the treatment of obesity, diabetes and addiction.  
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